Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance.
Clinical Benefit
| Substantial |
The transparency Committee considers that the actual benefit of ARAVA continues to be substantial in the indications in the Marketing Authorisation. |
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
hkWbJZfNQnK6Gnn3
Listen
